Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Results> Insilico Medicine (03696.HK) Expands Annual Loss to USD352 Million
Recommend 2 Positive 0 Negative 1 |
||||
|
||||
|
Insilico Medicine (03696.HK) announced its financial results for the fiscal year 2025, reporting revenue of USD56.24 million, a year-on-year decrease of 34.5%. The loss expanded from USD17.1 million in the previous year to USD352 million, with a loss per share of USD4.48. No final dividend was declared. (de/d) Auto-translated by third-party software This translation was auto-generated by third-party software. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
